← FDA Drug Approvals (Drugs@FDA)

PREVDUO

NDA · New Drug Application · Sponsor: AZURITY · Approved 2023-02-23

Drug application

FDA Application #

NDA216903

Application type

New Drug Application

Brand name

PREVDUO

Generic name

NEOSTIGMINE METHYLSULFATE AND GLYCOPYRROLATE

Active ingredients

GLYCOPYRROLATE; NEOSTIGMINE METHYLSULFATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

AZURITY

Manufacturer

Endo USA

First approval

2023-02-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown